Becker's Healthcare March 14, 2025
Alexandra Murphy

The FDA made recommendations to vaccine manufacturers for the virus strains to be used in the next batch of flu vaccines, according to a March 13 news release from the agency.

Respiratory illness levels remained moderate across the U.S., with influenza, COVID-19 and RSV activity declining, according to the latest CDC data. While flu remains the most prevalent virus, emergency department visits for flu were moderate and are expected to continue decreasing.

Three states are reporting “high” respiratory virus activity: Wisconsin, West Virginia and New Hampshire.

Here are four more updates:

  1. Influenza activity remained elevated but has been declining for four consecutive weeks. Flu-related emergency department visits remain moderate, and test positivity is at...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Public Health / COVID
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
HHS Explores Stronger FDA Oversight for Food Ingredients

Share This Article